Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03178045 · ClinicalTrials.gov registry record

Ambulatory Cancer Care Electronic Symptom Self-Reporting for Surgical Patients

A clinical trial of Patient Reported Outcomes, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
2,793
Enrollment target
1
Study location

NCT03178045: Completed study of Patient Reported Outcomes, sponsored by Memorial Sloan Kettering Cancer Center.

NCT03178045 is a study of Patient Reported Outcomes that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 2,793 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03178045, a study of Patient Reported Outcomes, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
2,793 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to understand and improve the experience of patients after surgery by comparing two methods of following symptoms while the patient recovers at home.

Primary Outcome

To compare the effectiveness of Team Monitoring and Enhanced Feedback with regard to urgent care, emergency department visits, and readmissions up to 30 days post-operatively.

Conditions Studied

Interventions

  • OTHER Team Monitoring
  • OTHER Enhanced Feedback

Study Locations (1)

New York

  • Memorial Sloan Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 2,793 participants
Start Date 2017-05-31
Est. Completion 2023-05-25
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT03178045 record still lists

NCT03178045 is an observational study that tracks outcomes without assigning an intervention. Its 2,793 participants enrollment target places it among the larger protocols in the corpus.

The record links to 1 condition, with Patient Reported Outcomes appearing as the primary indexed condition, and to 2 interventions - of which Team Monitoring is the first listed.

NCT03178045 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT03178045 about?

NCT03178045 is a clinical study titled "Ambulatory Cancer Care Electronic Symptom Self-Reporting for Surgical Patients". The aim of this study is to understand and improve the experience of patients after surgery by comparing two methods of following symptoms while the patient recovers at home.

What is the current status of trial NCT03178045?

This trial is currently completed. The enrollment target is 2,793 participants. The study started on 2017-05-31. Estimated completion is 2023-05-25.

What conditions does trial NCT03178045 study?

This clinical trial studies the following conditions: Patient Reported Outcomes.

What interventions are being tested in trial NCT03178045?

The interventions under investigation include: Team Monitoring (OTHER), Enhanced Feedback (OTHER).

Who is sponsoring clinical trial NCT03178045?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03178045 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Patient Reported Outcomes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05443737 · 2,800 participants · Phase 3

    Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients

  • NCT05899439 · 2,800 participants

    Immune Function and the Progression to T1D

  • NCT06089109 · 2,800 participants · NA

    Creating VIP Corps to Reduce Maternal Deaths

  • NCT06345339 · 2,800 participants · Phase 2

    A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03178045, the US trial registry maintained by the National Library of Medicine. NCT03178045 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.